Full-text resources of PSJD and other databases are now available in the new Library of Science.
Visit https://bibliotekanauki.pl


Preferences help
enabled [disable] Abstract
Number of results


2014 | 10 | 1 |

Article title

Insulin resistance and adipokine levels correlate with early atherosclerosis – a study in prediabetic patients


Title variants

Languages of publication



Cardiovascular risk of prediabetes is still
subject to controversies. We analyzed the associations
between insulin resistance, adipokines and incipient
atherosclerosis estimated by intima-media thickness
(IMT) in a cross-sectional study on 122 prediabetic
subjects without clinical signs of atherosclerotic disease.
Homeostasis model assessment of insulin resistance
(HOMA-IR, calculated as fasting insulin × fasting plasma
glucose / 22.5), adiponectin, leptin, leptin-to-adiponectin
ratio, carotid and femoral IMT were evaluated. We also
assessed other parameters related to insulin resistance and
adipokines (HbA1c, anthropometric and lipid parameters),
as they may also influence atherosclerosis. Carotid IMT was
correlated to adiponectin and leptin-to-adiponectin ratio
(all p < 0.05), but not with HOMA-IR or leptin, while
femoral IMT showed no relationship with these factors.
After adjusting for leptin, leptin-to-adiponectin ratio,
triglycerides, HDL-cholesterol, cholesterol-to-HDL ratio,
triglycerides-to-HDL ratio and HbA1c, IMT values became
correlated with HOMA-IR. Adjustment for HOMA-IR induced
the appearance of new correlations between adipokines
and both IMT values. In conclusion, insulin resistance and
adipokines seem related to IMT in prediabetic subjects
without clinical signs of arterial obstruction.








Physical description


14 - 1 - 2014
21 - 7 - 2014
26 - 9 - 2014


  • Discipline of Diabetes, Nutrition and Metabolic Diseases, First Medical Department, University of Medicine and Pharmacy ”Grigore T. Popa”, 16th Universității Street, 700115, Iași, Romania
  • Discipline of Internal Medicine and Cardiology, First Medical Department, University of Medicine and Pharmacy ”Grigore T. Popa”, 16th Universității Street, 700115, Iași, Romania
  • Discipline of Biochemistry, Morpho-Functional Sciences Department, University of Medicine and Pharmacy ”Grigore T. Popa”, 16th Universității Street, 700115, Iași, Romania
  • Discipline of Diabetes, Nutrition and Metabolic Diseases, First Medical Department, University of Medicine and Pharmacy ”Grigore T. Popa”, 16th Universității Street, 700115, Iași, Romania


  • [1] International Diabetes Federation, IDF Diabetes Atlas, 6th ed.,2013, 7-11
  • [2] Danaei G., Lawes C.M., Vander H.S., Murray C.J., Ezzati M.,Global and regional mortality from ischaemic heart diseaseand stroke attributable to higher-than-optimum blood glucoseconcentration: comparative risk assessment, Lancet, 2006,368, 1651-1659
  • [3] Ford E.S., Zhao G., Li C., Pre-diabetes and the risk for cardiovasculardisease. A systematic review of the evidence, J. Am.Coll. Cardiol., 2010, 55, 1310-1317[Crossref]
  • [4] Yadav A., Kataria M.A., Saini V., Yadav A., Role of leptin andadiponectin in insulin resistance, Clin. Chim. Acta., 2013, 417,80-84
  • [5] van de Voorde J., Pauwels B., Boydens C., Decaluwé K.,Adipocytokines in relation to cardiovascular disease,Metabolism, 2013, 62, 1513-1521[Crossref]
  • [6] Kim J.Y., Choi E.Y., Mun H.S., Min P.K., Yoon Y.W., Lee B.K., etal., Usefulness of metabolic syndrome score in the predictionof angiographic coronary artery disease severity according tothe presence of diabetes mellitus: relation with inflammatorymarkers and adipokines, Cardiovasc. Diabetol., 2013, 12, 140[Crossref]
  • [7] Lindberg S., Mogelvang R., Pedersen S.H., Bjerre M., FrystykJ., Flyvbjerg A., et al., Relation of serum adiponectin levels tonumber of traditional atherosclerotic risk factors and all-causemortality and major adverse cardiovascular events (fromthe Copenhagen City Heart Study), Am. J. Cardiol., 2013, 111,1139-1145
  • [8] Carmina E., Obesity, adipokines and metabolic syndrome inpolycystic ovary syndrome, Front. Horm. Res., 2013, 40, 40-50
  • [9] Bidulescu A., Liu J., Chen Z., Hickson D.A., Musani S.K.,Samdarshi T.E., et al., Associations of adiponectin and leptinwith incident coronary heart disease and ischemic stroke inafrican americans: the Jackson Heart Study, Front. Public.Health., 2013, 1, 16
  • [10] Watanabe T., Sato K., Itoh F., Wakabayashi K., Shichiri M.,Hirano T., Endogenous bioactive peptides as potentialbiomarkers for atherosclerotic coronary heart disease,Sensors, 2012, 12, 4974-4985[Crossref]
  • [11] Gilardini L., Pasqualinotto L., Di Matteo S., Caffetto K., CrociM., Girola A., et al., Factors associated with early atherosclerosisand arterial calcifications in young subjects with abenign phenotype of obesity, Obesity (Silver Spring), 2011, 19,1684-1689[Crossref]
  • [12] Touboul P.J., Hennerici M.G., Meairs S., Adams H., Amarenco P.,Bornstein N., et al., Mannheim carotid intima-media thicknessand plaque consensus (2004-2006-2011). An update on behalfof the advisory board of the 3rd, 4th and 5th watching therisk symposia, at the 13th, 15th and 20th European StrokeConferences, Mannheim, Germany, 2004, Brussels, Belgium,2006, and Hamburg, Germany, 2011, Cerebrovasc. Dis., 2012,34, 290-296
  • [13] Dullaart R.P., Kappelle P.J., Dallinga-Thie G.M., Carotid intimamedia thickness is associated with plasma adiponectin but notwith the leptin:adiponectin ratio independently of metabolicsyndrome, Atherosclerosis, 2010, 211, 393-396
  • [14] Juonala M., Saarikoski L.A., Viikari J.S., Oikonen M.,Lehtimäki T., Lyytikäinen L.P., et al., A longitudinal analysis onassociations of adiponectin levels with metabolic syndromeand carotid artery intima-media thickness. The CardiovascularRisk in Young Finns Study, Atherosclerosis, 2011, 217, 234-239
  • [15] World Health Organization & International Diabetes Federation,Definition and diagnosis of diabetes mellitus and intermediatehyperglycemia: report of a WHO/IDF consultation, WHO Press,Geneva, 2006, 1-36
  • [16] Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C.,Green L.A., Izzo J.L.Jr., et al., and the National High BloodPressure Education Program Coordinating Committee,Seventh report of the Joint National Committee on prevention,detection, evaluation, and treatment of high blood pressure,Hypertension, 2003, 42, 1206-1252[Crossref]
  • [17] Jellinger P.S., Smith D.A., Mehta A.E., Ganda O., Handelsman Y.,Rodbard H.W., et al., and the AACE Task Force for Managementof Dyslipidemia and Prevention of Atherosclerosis., AmericanAssociation of Clinical Endocrinologists’ guidelines formanagement of dyslipidemia and prevention of atherosclerosis,Endocr. Pract., 2012, 18, 1-78[Crossref]
  • [18] Redberg R.F., Vogel R.A., Criqui M.H., Herrington D.M., LimaJ.A., Roman M.J., 34th Bethesda Conference, Task force #3,What is the spectrum of current and emerging techniques forthe noninvasive measurement of atherosclerosis?, J. Am. Coll.Cardiol., 2003, 41, 1886-1898
  • [19] Faeh D., William J., Yerly P., Paccaud F., Bovet P., Diabetes andpre-diabetes are associated with cardiovascular risk factorsand carotid/femoral intima-media thickness independentlyof markers of insulin resistance and adiposity, Cardiovasc.Diabetol., 2007, 6, 32, DOI: 10.1186/1475-2840-6-32[Crossref]
  • [20] Vaudo G., Marchesi S., Siepi D., Brozzetti M., Mannarino M.R.,Pirro M., et al., Metabolic syndrome and preclinical atherosclerosis:focus on femoral arteries, Metabolism, 2007, 56:541-546[Crossref]
  • [21] Doruk H., Mas M.R., Ateşkan U., Isik A.T., Sağlam M., Kutlu M.,The relationship between age and carotid artery intima-mediathickness, hemoglobin A1c in nondiabetic, healthy geriatricpopulation, Arch. Gerontol. Geriatr., 2005, 41, 113-119
  • [22] Fujisawa M., Okumiya K., Matsubayashi K., Hamada T., EndoH., Doi Y., Factors associated with carotid atherosclerosis incommunity-dwelling oldest elderly aged over 80 years, Geriatr.Gerontol. Int., 2008, 8, 12-18[Crossref]
  • [23] Juonala M., Kähönen M., Laitinen T., Hutri-Kähönen N.,Jokinen E., Taittonen L., et al., Effect of age and sex on carotidintima-media thickness, elasticity and brachial endothelialfunction in healthy adults: the cardiovascular risk in YoungFinns Study, Eur. Heart. J., 2008, 29, 1198-1206[Crossref]
  • [24] Hacihamdioğlu B., Okutan V., Yozgat Y., Yildirim D., KocaoğluM., Lenk M.K., et al., Abdominal obesity is an independent riskfactor for increased carotid intima-media thickness in obesechildren, Turk. J. Pediatr., 2011, 53, 48-54
  • [25] Maher V., O’Dowd M., Carey M., Markham C., Byrne A., HandE., et al., Association of central obesity with early carotidintima-media thickening is independent of that from other riskfactors, Int. J. Obes., 2009, 33, 136-143[Crossref]
  • [26] Luksiene D.I., Petkeviciene J., Jureniene K., Klumbiene J.,Smalinskiene A., Tamosiunas A., Association between anthropometricindexes and cardiovascular risk factors, Cent. Eur. J.Med., 2011, 6, 411-417
  • [27] Acevedo M., Krämer V., Tagle R., Corbalán R., Arnaíz P., BerríosX., et al., Total/HDL cholesterol ratio and non HDL cholesterolas predictors for increased intima media thickness, Rev. Med.Chil., 2012, 140, 969-976
  • [28] Enomoto M., Adachi H., Hirai Y., Fukami A., Satoh A., OtsukaM., et al., LDL-C/HDL-C ratio predicts carotid intima-mediathickness progression better than HDL-C or LDL-C alone., J.Lipids., 2011, DOI: 10.1155/2011/549137[Crossref]
  • [29] Kavazarakis E., Moustaki M., Gourgiotis D., Drakatos A.,Bossios A., Zeis P.M., et al., Relation of serum leptin levelsto lipid profile in healthy children, Metabolism, 2001, 50,1091-1094[Crossref]
  • [30] Tungtrongchitr R., Pongpaew P., Phonrat B., Tribunyatkul S.,Viroonudomphol D., Supawan V., et al., Serum leptin and lipidprofiles in Thai obese and overweight subjects, Int. J. Vitam.Nutr. Res., 2001, 71, 74-81
  • [31] Marso S.P., Mehta S.K., Frutkin A., House J.A., McCrary J.R.,Kulkarni K.R., Low adiponectin levels are associated withatherogenic dyslipidemia and lipid-rich plaque in nondiabeticcoronary arteries, Diabetes Care, 2008, 31, 989-994
  • [32] von Eynatten M., Hamann A., Twardella D., Nawroth P.P.,Brenner H., Rothenbacher D., Relationship of adiponectin withmarkers of systemic inflammation, atherogenic dyslipidemia,and heart failure in patients with coronary heart disease, Clin.Chem., 2006, 52, 853-859[Crossref]
  • [33] Avramoglu R.K., Basciano H., Adeli K., Lipid and lipoproteindysregulation in insulin resistant states, Clin. Chim. Acta.,2006, 368, 1-19
  • [34] Ristic P., Bokonjic D., Zivkovic V., Jakovljevic V., Zdravkovic M.,Pejovic J., et al., Subcutaneous adipose tissue measurementsand better metabolic prediction, Cent. Eur. J. Med., 2013, 8,237-243
  • [35] Moriya M., Okumura T., Takahashi N., Yamagata K., MotomuraW., Kohgo Y., An inverse correlation between serum leptinlevels and hemoglobin A1c in patients with non-insulindependent diabetes mellitus, Diabetes Res. Clin. Pract., 1999,43, 187-191
  • [36] Taghdir M., Djazayeri A., Djalali M., Eshraghian M., Rajab A.,Yegane H.S., et al., Relationships of serum leptin concentrationwith insulin, glucose, HbA1c levels and insulin resistancein overweight post-menopausal diabetic women, ARYAAtheroscler. J., 2010, 5, 175-180
  • [37] Hadaegh F., Shafiee G., Ghasemi A., Sarbakhsh P., Azizi F.,Impact of metabolic syndrome, diabetes and prediabeteson cardiovascular events: Tehran Lipid and Glucose Study,Diabetes Res. Clin. Pract., 2010, 87, 342-347
  • [38] Zhang Y.F., Hong J., Zhan W.W., Li X.Y., Gu W.Q., Yang Y.S., etal., Hyperglycaemia after glucose loading is a major predictorof preclinical atherosclerosis in nondiabetic subjects, Clin.Endocrinol., 2006, 64, 153-157[Crossref]
  • [39] Marini M.A., Succurro E., Castaldo E., Cufone S., Arturi F.,Sciacqua A., et al., Cardiometabolic risk profiles and carotidatherosclerosis in individuals with prediabetes identified byfasting glucose, postchallenge glucose, and hemoglobin A1ccriteria, Diabetes Care, 2012, 35, 1144-1149
  • [40] Bansilal S., Farkouh M.E., Fuster V., Role of insulin resistanceand hyperglycemia in the development of atherosclerosis, Am.J. Cardiol., 2007, 99, 6B-14B
  • [41] Muniyappa R., Lantorno M., Quon M.J., An integrated view ofinsulin resistance and endothelial dysfunction, Endocrinol.Metab. Clin. North. Am., 2008, 37, 685-711[Crossref]
  • [42] Oliveira C.S.V., Giuffrida F.M.A., Crispim F., Saddi-Rosa P.,Reis A.F., ADIPOQ and adiponectin: the common groundof hyperglycemia and coronary artery disease?, Arq. Bras.Endocrinol. Metabol., 2011, 55, 446-454[Crossref]
  • [43] Hedblad B., Nilsson P., Janzon L., Berglund G., Relationbetween insulin resistance and carotid intima-media thicknessand stenosis in non-diabetic subjects. Results from a crosssectionalstudy in Malmo, Sweden, Diabet. Med., 2000, 17,299-307[Crossref]
  • [44] de Lima Sanches P., de Mello M.T., Elias N., Fonseca F.A.H,de Piano A., Carnier J., et al., Improvement in HOMA-IR isan independent predictor of reduced carotid intima-mediathickness in obese adolescents participating in an interdisciplinaryweight-loss program, Hypertens. Res., 2011, 34,232-238[Crossref]
  • [45] Viscogliosi G., Andreozzi P., Marigliano V., Associations ofplasma glucose levels and traits of metabolic syndrome withcarotid intima media thickness in nondiabetic elderly subjects:are they mediated by insulin resistance?, Metab. Syndr. Relat.Disord., 2013, 11, 41-45[Crossref]
  • [46] Finucane F.M., Luan J., Wareham N.J., Sharp S.J., O’RahillyS., Balkau B., et al., European Group for the Study of InsulinResistance: Relationship between Insulin Sensitivity andCardiovascular Disease Risk Study Group, Savage DB.Correlation of the leptin:adiponectin ratio with measures ofinsulin resistance in non-diabetic individuals, Diabetologia,2009, 52, 2345–2349[Crossref]
  • [47] Pilz S., Horejsi R., Moller R., Almer G., Scharnagl H., StojakovicT., et al., Early atherosclerosis in obese juveniles is associatedwith low serum levels of adiponectin., J. Clin. Endocrinol.Metab., 2005, 90, 4792-4796[Crossref]
  • [48] Lo J., Dolan S.E., Kanter J.R., Hemphill L.C., Connelly J.M.,Lees R.S., et al., Effects of obesity, body composition, andadiponectin on carotid intima-media thickness in healthywomen., J. Clin. Endocrinol. Metab., 2006, 91, 1677-1682[Crossref]
  • [49] Kojima S., Funahashi T., Maruyoshi H., Honda O., Sugiyama S.,Kawano H., et al., Levels of adipocyte-derived plasma protein, adiponectin, have a close relationship with atheroma., Thromb.Res., 2005, 115, 483-490
  • [50] Perticone F., Maio R., Sciacqua A., Andreozzi F., Iemma G.,Perticone M., et al., Endothelial dysfunction and C-reactiveprotein are risk factors for diabetes in essential hypertension,Diabetes, 2008, 57, 167–171[Crossref]
  • [51] Ridker P.M., Hennekens C.H., Buring J.E., Rifai N., C-reactiveprotein and other markers of inflammation in the prediction ofcardiovascular disease in women., N. Engl. J. Med., 2000, 342,836-843
  • [52] Nilsson P.M., Engström G., Hedblad B., Frystyk J., PerssonM.M., Berglund G., et al., Plasma adiponectin levels inrelation to carotid intima media thickness and markers ofinsulin resistance, Arterioscler. Thromb. Vasc. Biol., 2006, 26,2758-2762[Crossref]
  • [53] Pischon T., Girman C.J., Hotamisligil G.S., Rifai N., Hu F.B.,Rimm E.B., Plasma adiponectin levels and risk of myocardialinfarction in men, JAMA, 2004, 291, 1730-1737
  • [54] Dallinga-Thie G.M., Dullaart R.P.F., Do genome-wideassociation scans provide additional information on thevariation of plasma adiponectin concentrations?, Atherosclerosis,2010, 208, 328–329
  • [55] Ciccone M., Vettor R., Pannacciulli N., Minenna A., BellaciccoM., Rizzon P., et al., Plasma leptin is independently associatedwith the intima-media thickness of the common carotid artery,Int. J. Obes. Relat. Metab. Disord., 2001, 25, 805-810[Crossref]
  • [56] Norata G.D., Raselli S., Grigore L., Garlaschelli K., Dozio E.,Magni P., et al., Leptin:adiponectin ratio is an independentpredictor of intima media thickness of the common carotidartery, Stroke, 2007, 38, 2844–2846[Crossref]
  • [57] Kotani K., Sakane N., Saiga K., Kurozawa Y.,Leptin:adiponectin ratio as an atherosclerotic index inpatients with type 2 diabetes: relationship of the index tocarotid intima-media thickness, Diabetologia, 2005, 48,2684–2686
  • [58] Gast K.B., Tjeerdema N., Stijnen T., Smit J.W., Dekkers O.M.,Insulin resistance and risk of incident cardiovascular eventsin adults without diabetes: meta-analysis, PLoS One, 2012, 7,e52036, DOI: 10.1371/journal.pone.0052036[Crossref]
  • [59] Mancini G.B.J., Dahlöf B., Díez J., Surrogate Markers for CardiovascularDisease: Structural Markers, Circulation, 2004, 109,IV-22-IV-30, DOI: 10.1161/01.CIR.0000133443.77237.2f [Crossref]

Document Type

Publication order reference


YADDA identifier

JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.